Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Shr4640
1. 1638327-48-6
2. Shr-4640
3. Shr4640
4. Up8j9ca76i
5. 1-((6-bromo-4-quinolinyl)thio)cyclobutanecarboxylic Acid
6. Cyclobutanecarboxylic Acid, 1-((6-bromo-4-quinolinyl)thio)-
7. Refchem:180385
8. 1-((6-bromoquinolin-4-yl)thio)cyclobutane-1-carboxylic Acid
9. Chembl3746329
10. 1-(6-bromoquinolin-4-yl)sulfanylcyclobutane-1-carboxylic Acid
11. Ruzinurad [inn]
12. Unii-up8j9ca76i
13. Orb1691557
14. Schembl16247926
15. Schembl30411665
16. Dtxsid601358949
17. Bdbm50134635
18. Ex-a11346
19. Akos040756957
20. Hy-w052011
21. Da-77595
22. Ms-25138
23. Cs-0044660
24. D72706
25. 1-((6-bromoquinolin-4-yl)thio)cyclobutanecarboxylic Acid
26. 1-((6-bromoquinolin-4-yl)thio)cyclobutane-1-carboxylicacid
27. 1-[(6-bromo-4-quinolyl)sulfanyl]cyclobutanecarboxylic Acid
| Molecular Weight | 338.22 g/mol |
|---|---|
| Molecular Formula | C14H12BrNO2S |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 75.5 |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 361 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
26
PharmaCompass offers a list of Ruzinurad API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ruzinurad manufacturer or Ruzinurad supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ruzinurad manufacturer or Ruzinurad supplier.
A Ruzinurad manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ruzinurad, including repackagers and relabelers. The FDA regulates Ruzinurad manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ruzinurad API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ruzinurad supplier is an individual or a company that provides Ruzinurad active pharmaceutical ingredient (API) or Ruzinurad finished formulations upon request. The Ruzinurad suppliers may include Ruzinurad API manufacturers, exporters, distributors and traders.
Ruzinurad Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ruzinurad GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ruzinurad GMP manufacturer or Ruzinurad GMP API supplier for your needs.
A Ruzinurad CoA (Certificate of Analysis) is a formal document that attests to Ruzinurad's compliance with Ruzinurad specifications and serves as a tool for batch-level quality control.
Ruzinurad CoA mostly includes findings from lab analyses of a specific batch. For each Ruzinurad CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ruzinurad may be tested according to a variety of international standards, such as European Pharmacopoeia (Ruzinurad EP), Ruzinurad JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ruzinurad USP).
